International Study to Predict Optimised Treatment - in Depression.
Phase of Trial: Phase IV
Latest Information Update: 01 Feb 2017
At a glance
- Drugs Escitalopram (Primary) ; Sertraline (Primary) ; Venlafaxine (Primary)
- Indications Major depressive disorder
- Focus Biomarker; Pharmacodynamics; Pharmacogenomic
- Acronyms iSPOT-D
- Sponsors BRC Operations
- 19 Jan 2017 Planned End Date changed from 1 Feb 2015 to 1 Apr 2018.
- 07 Mar 2013 Planned end date changed from 1 Dec 2013 to 1 Feb 2015 as reported by ClinicalTrials.gov.
- 06 Feb 2012 Additional lead trial investigators identified as reported by ClinicalTrials.gov.